Verisk Health Appoints Nathan Gunn, M.D., as Chief Medical Officer

WALTHAM, Mass., March 25, 2009 — Verisk Health, Inc., a leading healthcare data analytics firm that delivers solutions to minimize medical and financial risk, today announced the appointment of Nathan Gunn, M.D., as chief medical officer. Dr. Gunn will manage scientific and clinical research operations, develop and maintain clinical content and intellectual property, and oversee the clinical content of Verisk Health software products.

Prior to leading the clinical team at Verisk Health, Dr. Gunn was the senior vice president of Clinical Solutions at D2Hawkeye, which merged with Verisk Health, a subsidiary of ISO, in January 2009. Before joining D2Hawkeye, Dr. Gunn served at McKinsey and Company, where he counseled industry and government leaders nationally and internationally on provider operations and growth strategies, private equity, and international health system reform and design. Dr. Gunn completed his residency in internal medicine at the University of California at San Francisco and currently serves as a part-time attending physician at the San Francisco Veterans Affairs Medical Center.

“Nathan’s command of medical science and his grasp of clinical issues put him at the forefront of healthcare data analytics and risk management,” said Chris Kryder, M.D., CEO of Verisk Health. “We are fortunate to have him engaged in developing new approaches to managing clinical and financial risk, enabling our clients to control costs and improve patient outcomes.”

About Verisk Health
Verisk Health leverages healthcare data to help businesses understand their medical and financial risk to better manage costs and clinical outcomes. By combining the leading predictive science with the finest evidence-based clinical engine, and powering it with superior technology, we have created the most extensive independent risk-assessment and decision-analytics platform in the healthcare industry. Our complete focus is on identifying actionable strategies for managing healthcare costs and quality at both the individual and population level. By growing and investing in our own business, we have become agents of change in our clients’ businesses and in the industry. Verisk Health is a wholly owned subsidiary of ISO. For more information, please visit

Release: Immediate

Rosa Randazzo
Verisk Health

Archived Press